{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:18:48Z","timestamp":1790565528246,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93021C00045"],"award-info":[{"award-number":["75N93021C00045"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127409","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T23:24:21Z","timestamp":1750461861000},"page":"127409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["COVID-19 vaccine (NVX-CoV2373 and NVX-CoV2540) doses and virus strain match impact sex- and age-specific immunity and protection in mice"],"prefix":"10.1016","volume":"61","author":[{"given":"Sabal","family":"Chaulagain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaiprasath","family":"Sachithanandham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Creisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Sol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Guebre-Xabier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gale","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pekosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabra L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2025.127409_bb0005","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","article-title":"Considering how biological sex impacts immune responses and COVID-19 outcomes","volume":"20","author":"Scully","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2025.127409_bb0010","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"New England journal of medicine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127409_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13293-020-00304-9","article-title":"Impact of sex and gender on COVID-19 outcomes in Europe","volume":"11","author":"Gebhard","year":"2020","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.vaccine.2025.127409_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.114716","article-title":"Sex disparities in COVID-19 outcomes in the United States: quantifying and contextualizing variation","volume":"294","author":"Danielsen","year":"2022","journal-title":"Soc Sci Med"},{"issue":"20","key":"10.1016\/j.vaccine.2025.127409_bb0025","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127409_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101205","article-title":"Aging in COVID-19: vulnerability, immunity and intervention","volume":"65","author":"Chen","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"7849","key":"10.1016\/j.vaccine.2025.127409_bb0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/d41586-021-00577-z","article-title":"COVID-19: use intersectional analyses to close gaps in outcomes and vaccination","volume":"591","author":"Shapiro","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127409_bb0040","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s11606-021-06699-4","article-title":"Sex disparities in COVID-19 mortality vary across US racial groups","volume":"36","author":"Rushovich","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.vaccine.2025.127409_bb0045","article-title":"Sex and gender differences in testing, hospital admission, clinical presentation, and drivers of severe outcomes from COVID-19. Open forum","volume":"8(9):ofab448","author":"Scully","year":"2021","journal-title":"Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127409_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00974-21","article-title":"Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 Golden Syrian Hamster model","volume":"12","author":"Dhakal","year":"2021","journal-title":"mBio"},{"issue":"7837","key":"10.1016\/j.vaccine.2025.127409_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"Takahashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.127409_bb0060","author":"WHO"},{"key":"10.1016\/j.vaccine.2025.127409_bb0065","author":"CDC"},{"key":"10.1016\/j.vaccine.2025.127409_bb0070","first-page":"225","article-title":"Sex-differential and non-specific effects of vaccines over the life course","volume":"441","author":"St Clair","year":"2023","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127409_bb0075","article-title":"Attention for sex in COVID-19 trials: a review of regulatory dossiers","volume":"7","author":"Vries","year":"2022","journal-title":"Bmj Global Heal"},{"key":"10.1016\/j.vaccine.2025.127409_bb0080","doi-asserted-by":"crossref","first-page":"106700","DOI":"10.1016\/j.cct.2022.106700","article-title":"COVID-19 vaccines: considering sex differences in efficacy and safety","volume":"115","author":"Jensen","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127409_bb0085","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1080\/21645515.2021.1984135","article-title":"Is there a difference in the efficacy of COVID-19 vaccine in males and females? - a systematic review and meta-analysis","volume":"17","author":"Zhu","year":"2021","journal-title":"Hum Vacc Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127409_bb0090","first-page":"1322","article-title":"A systematic review of the sex and gender reporting in COVID-19 clinical trials","volume":"9","author":"Heidari","year":"2021","journal-title":"Nato Adv Sci Inst Se"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127409_bb0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s43856-023-00297-7","article-title":"Sex-disaggregated effectiveness data reporting in COVID-19 vaccine research: a systematic review","volume":"3","author":"Sulis","year":"2023","journal-title":"Commun Med (Lond)."},{"issue":"9","key":"10.1016\/j.vaccine.2025.127409_bb0100","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S2213-2600(21)00220-4","article-title":"BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-Centre, longitudinal cohort study in health-care workers","volume":"9","author":"Lustig","year":"2021","journal-title":"Lancet Respir Medicine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127409_bb0105","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/infdis\/jiab314","article-title":"COVID-19 mRNA vaccination generates greater IgG levels in women compared to men","volume":"224","author":"Demonbreun","year":"2021","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127409_bb0110","article-title":"Serological response after SARS-CoV2 vaccination in healthcare workers: a multicenter study","volume":"113","author":"Visci","year":"2022","journal-title":"Med Lav"},{"key":"10.1016\/j.vaccine.2025.127409_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.836923","article-title":"Markers of memory CD8 T cells depicting the effect of the BNT162b2 mRNA COVID-19 vaccine in Japan","volume":"13","author":"Kondo","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127409_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.07.042","article-title":"Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan","volume":"27","author":"Kageyama","year":"2021","journal-title":"Clin Microbiol Infec"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.127409_bb0125","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1093\/cid\/ciac397","article-title":"Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults","volume":"75","author":"Shapiro","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127409_bb0130","first-page":"1","article-title":"Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review","author":"Notarte","year":"2022","journal-title":"Crit Rev Cl Lab Sci"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127409_bb0135","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127409_bb0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40520-025-02990-0","article-title":"COVID-19 Booster Doses Reduce Sex Disparities in Antibody Responses among Nursing Home Residents","volume":"37","author":"Oyebanji","year":"2025","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127409_bb0145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice","volume":"12","author":"Tian","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127409_bb0150","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/14760584.2023.2218913","article-title":"Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine","volume":"22","author":"Underwood","year":"2023","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127409_bb0155","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00326-24","article-title":"Estradiol mediates greater germinal center responses to influenza vaccination in female than male mice","volume":"15","author":"Dhakal","year":"2024","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127409_bb0160","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1038\/s41467-022-30763-0","article-title":"Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera","volume":"13","author":"Rathnasinghe","year":"2022","journal-title":"Nat Commun"},{"issue":"32","key":"10.1016\/j.vaccine.2025.127409_bb0165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2310917121","article-title":"Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among omicron subvariants","volume":"121","author":"M\u00fchlemann","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127409_bb0170","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00948-24","article-title":"Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1","volume":"98","author":"Wang","year":"2024","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127409_bb0175","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.127409_bb0180","first-page":"100221","article-title":"Immunogenicity to SARS-CoV-2 omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster","volume":"12","author":"Chantasrisawad","year":"2022","journal-title":"Vaccine: X"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127409_bb0185","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1056\/NEJMc2214916","article-title":"Neutralization of BA.4\u2013BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with bivalent vaccine","volume":"388","author":"Zou","year":"2023","journal-title":"New England Journal of Medicine."},{"issue":"2","key":"10.1016\/j.vaccine.2025.127409_bb0190","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/acs.jcim.1c01451","article-title":"Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance","volume":"62","author":"Chen","year":"2022","journal-title":"J Chem Inf Model"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127409_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.02.017","article-title":"Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants","volume":"57","author":"Johnston","year":"2024","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127409_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.02.016","article-title":"Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans","volume":"57","author":"Tortorici","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2025.127409_bb0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-019-0124-6","article-title":"Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females","volume":"4","author":"Potluri","year":"2019","journal-title":"NPJ Vaccines"},{"issue":"49","key":"10.1016\/j.vaccine.2025.127409_bb0210","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.1073\/pnas.1805268115","article-title":"Biological sex affects vaccine efficacy and protection against influenza in mice","volume":"115","author":"Fink","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127409_bb0215","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1073\/pnas.1321060111","article-title":"Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination","volume":"111","author":"Furman","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127409_bb0220","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/s41467-018-04408-0","article-title":"Testosterone is an endogenous regulator of BAFF and splenic B cell number","volume":"9","author":"Wilhelmson","year":"2018","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127409_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009724","article-title":"A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cells","volume":"17","author":"Ko","year":"2021","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127409_bb0230","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/infdis\/jiac199","article-title":"Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine but strong initial responses to a third dose","volume":"226","author":"Mwimanzi","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127409_bb0235","author":"CDC"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127409_bb0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41421-023-00585-5","article-title":"Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine","volume":"9","author":"Guo","year":"2023","journal-title":"Cell Discovery"},{"issue":"7911","key":"10.1016\/j.vaccine.2025.127409_bb0245","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41586-022-04690-5","article-title":"Defining the risk of SARS-CoV-2 variants on immune protection","volume":"605","author":"DeGrace","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.127409_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104008","article-title":"The displacement of the SARS-CoV-2 variant Delta with omicron: an investigation of hospital admissions and upper respiratory viral loads","volume":"79","author":"Fall","year":"2022","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127409_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/v16091436","article-title":"SARS-CoV-2 variants from long-term, persistently infected immunocompromised patients have altered syncytia formation, temperature-dependent replication, and serum neutralizing antibody escape","volume":"16","author":"Wouters","year":"2024","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127409_bb0260","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.vaccine.2020.11.057","article-title":"Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice","volume":"40","author":"Dhakal","year":"2022","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127409_bb0265","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1172\/JCI142004","article-title":"Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population","volume":"130","author":"Klein","year":"2020","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127409_bb0270","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s43856-024-00658-w","article-title":"Application of machine learning algorithms to identify serological predictors of COVID-19 severity and outcomes","volume":"4","author":"Dhakal","year":"2024","journal-title":"Commun Med (Lond)"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127409_bb0275","article-title":"Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial. JCI","volume":"9","author":"Park","year":"2024","journal-title":"Insight"},{"key":"10.1016\/j.vaccine.2025.127409_bb0280","doi-asserted-by":"crossref","first-page":"1266370","DOI":"10.3389\/fimmu.2023.1266370","article-title":"Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies","volume":"14","author":"Lee","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127409_bb0285","first-page":"e01839","article-title":"Greater breadth of vaccine-induced immunity in females than males is mediated by increased antibody diversity in germinal Center B cells","volume":"13","author":"Ursin Rebecca","year":"2022","journal-title":"mBio"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25007066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:43:24Z","timestamp":1762278204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25007066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":57,"alternative-id":["S0264410X25007066"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127409","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccine (NVX-CoV2373 and NVX-CoV2540) doses and virus strain match impact sex- and age-specific immunity and protection in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127409"}}